$AXON
AXON ENTERPRISE, INC.

2021 Q2 Form 10-Q Financial Statement

#000155837021010634 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $218.8M $141.3M
YoY Change 54.89% 25.72%
Cost Of Revenue $80.87M $53.08M
YoY Change 52.34% 13.42%
Gross Profit $137.9M $88.18M
YoY Change 56.42% 34.5%
Gross Profit Margin 63.04% 62.42%
Selling, General & Admin $177.7M $72.29M
YoY Change 145.75% 66.72%
% of Gross Profit 128.81% 81.99%
Research & Development $53.95M $29.56M
YoY Change 82.52% 25.82%
% of Gross Profit 39.12% 33.52%
Depreciation & Amortization $4.292M $2.930M
YoY Change 46.48% 8.92%
% of Gross Profit 3.11% 3.32%
Operating Expenses $231.6M $101.9M
YoY Change 127.4% 52.35%
Operating Profit -$93.69M -$13.68M
YoY Change 585.03% 956.06%
Interest Expense $41.84M $1.613M
YoY Change 2493.99% -12.57%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$51.84M -$12.06M
YoY Change 329.78% -2293.27%
Income Tax -$4.727M $18.70M
% Of Pretax Income
Net Earnings -$47.12M -$30.76M
YoY Change 53.18% -4267.89%
Net Earnings / Revenue -21.53% -21.77%
Basic Earnings Per Share -$0.72 -$0.51
Diluted Earnings Per Share -$0.72 -$0.51
COMMON SHARES
Basic Shares Outstanding 65.17M 60.35M
Diluted Shares Outstanding 65.17M 60.35M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $655.3M $557.2M
YoY Change 17.6% 65.69%
Cash & Equivalents $266.4M $319.3M
Short-Term Investments $388.9M $238.0M
Other Short-Term Assets $45.46M $42.40M
YoY Change 7.21% 16.48%
Inventory $91.74M $81.01M
Prepaid Expenses
Receivables $288.5M $205.1M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.081B $885.7M
YoY Change 22.04% 54.02%
LONG-TERM ASSETS
Property, Plant & Equipment $119.9M $45.39M
YoY Change 164.25% 12.06%
Goodwill $25.18M $24.91M
YoY Change 1.1% -0.26%
Intangibles $7.870M $11.15M
YoY Change -29.39% -22.73%
Long-Term Investments $107.2M $136.9M
YoY Change -21.7%
Other Assets $84.24M $63.81M
YoY Change 32.03% 79.26%
Total Long-Term Assets $446.0M $347.2M
YoY Change 28.45% 102.66%
TOTAL ASSETS
Total Short-Term Assets $1.081B $885.7M
Total Long-Term Assets $446.0M $347.2M
Total Assets $1.527B $1.233B
YoY Change 23.84% 65.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.778M $40.11M
YoY Change -80.61% 342.46%
Accrued Expenses $66.91M $64.47M
YoY Change 3.79% 89.55%
Deferred Revenue $186.9M $129.5M
YoY Change 44.31% 14.26%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $272.9M $242.8M
YoY Change 12.37% 48.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $32.36M $28.24M
YoY Change 14.6% -69.9%
Total Long-Term Liabilities $32.36M $28.24M
YoY Change 14.6% -69.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $272.9M $242.8M
Total Long-Term Liabilities $32.36M $28.24M
Total Liabilities $429.2M $363.1M
YoY Change 18.2% 41.04%
SHAREHOLDERS EQUITY
Retained Earnings $74.87M $144.9M
YoY Change -48.35% -18.82%
Common Stock $1.179B $883.6M
YoY Change 33.43% 88.84%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares $20.22M $20.22M
Shareholders Equity $1.098B $869.8M
YoY Change
Total Liabilities & Shareholders Equity $1.527B $1.233B
YoY Change 23.84% 65.19%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$47.12M -$30.76M
YoY Change 53.18% -4267.89%
Depreciation, Depletion And Amortization $4.292M $2.930M
YoY Change 46.48% 8.92%
Cash From Operating Activities $34.18M -$20.40M
YoY Change -267.52% -279.1%
INVESTING ACTIVITIES
Capital Expenditures -$13.61M -$5.410M
YoY Change 151.65% 94.6%
Acquisitions
YoY Change
Other Investing Activities $94.18M -$118.7M
YoY Change -179.32% 946.08%
Cash From Investing Activities $80.57M -$124.1M
YoY Change -164.9% 779.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.262M 306.5M
YoY Change -101.06% -35326.44%
NET CHANGE
Cash From Operating Activities 34.18M -20.40M
Cash From Investing Activities 80.57M -124.1M
Cash From Financing Activities -3.262M 306.5M
Net Change In Cash 111.5M 161.9M
YoY Change -31.16% -4598.06%
FREE CASH FLOW
Cash From Operating Activities $34.18M -$20.40M
Capital Expenditures -$13.61M -$5.410M
Free Cash Flow $47.79M -$14.99M
YoY Change -418.81% -205.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001069183
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Local Phone Number
LocalPhoneNumber
991-0797
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65674346
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63766555
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-16391
dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei City Area Code
CityAreaCode
480
dei Trading Symbol
TradingSymbol
AXON
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65675685
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266372000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155440000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
388895000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
406525000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1973000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2105000
CY2021Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
201907000
CY2020Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
229201000
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
86561000
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
63945000
CY2021Q2 us-gaap Inventory Net
InventoryNet
91739000
CY2020Q4 us-gaap Inventory Net
InventoryNet
89958000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
45456000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36883000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1080930000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
981952000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
119933000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105494000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
52387000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
45770000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7870000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9448000
CY2021Q2 us-gaap Goodwill
Goodwill
25178000
CY2020Q4 us-gaap Goodwill
Goodwill
25205000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
48669000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
90681000
CY2021Q2 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
17466000
CY2020Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
22457000
CY2021Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
31691000
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
20099000
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11711000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84244000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68206000
CY2021Q2 us-gaap Assets
Assets
1526888000
CY2020Q4 us-gaap Assets
Assets
1381023000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7778000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24142000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66908000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59843000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6404000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5431000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
272871000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
256331000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
113815000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4550000
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4503000
CY2021Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5216000
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4732000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
377000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
649000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32360000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27331000
CY2021Q2 us-gaap Liabilities
Liabilities
429189000
CY2020Q4 us-gaap Liabilities
Liabilities
404768000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65674346
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63766555
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1179005000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
962159000
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74867000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
169901000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-227000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
141000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097699000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1526888000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1381023000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218795000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141259000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413814000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288421000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
80866000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53082000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
152532000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111636000
CY2021Q2 us-gaap Gross Profit
GrossProfit
137929000
CY2020Q2 us-gaap Gross Profit
GrossProfit
88177000
us-gaap Gross Profit
GrossProfit
261282000
us-gaap Gross Profit
GrossProfit
176785000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
177662000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72293000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
304259000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135320000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53952000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29560000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100970000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55941000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
231614000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
101853000
us-gaap Operating Expenses
OperatingExpenses
405229000
us-gaap Operating Expenses
OperatingExpenses
191261000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-93685000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13676000
us-gaap Operating Income Loss
OperatingIncomeLoss
-143947000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14476000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
41841000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1613000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
42426000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2554000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51844000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12063000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101521000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11922000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4727000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18696000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6487000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14763000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-30759000
us-gaap Net Income Loss
NetIncomeLoss
-95034000
us-gaap Net Income Loss
NetIncomeLoss
-26685000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65166000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60346000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64604000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59977000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65166000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60346000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64604000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59977000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-30759000
us-gaap Net Income Loss
NetIncomeLoss
-95034000
us-gaap Net Income Loss
NetIncomeLoss
-26685000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-369000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
678000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-368000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1694000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47486000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30081000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95402000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28379000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-7045000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89610000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1010904000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-3268000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
137549000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-369000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1097699000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
543495000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-5162000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20195000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
4074000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2372000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
559590000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
306779000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-310000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33835000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-30759000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
678000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
869813000
us-gaap Profit Loss
ProfitLoss
-95034000
us-gaap Profit Loss
ProfitLoss
-26685000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8582000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5811000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-130000
us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-113000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-43000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1305000
us-gaap Gain Loss On Investments
GainLossOnInvestments
40855000
us-gaap Share Based Compensation
ShareBasedCompensation
227159000
us-gaap Share Based Compensation
ShareBasedCompensation
54030000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6889000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6152000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
47000
axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
612000
us-gaap Other Noncash Expense
OtherNoncashExpense
5760000
us-gaap Other Noncash Expense
OtherNoncashExpense
2596000
axon Credit Loss Reserve
CreditLossReserve
62000
axon Credit Loss Reserve
CreditLossReserve
658000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
3988000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
9375000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1848000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
43271000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
13320000
axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
8551000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10381000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
16708000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25647000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5224000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
95115000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
14546000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24031000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7551000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
48000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
78000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
143000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6977000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
238288000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
292597000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
294814000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
158670000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
20500000
axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
4700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26446000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146211000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
306779000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
295000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10312000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5767000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10312000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301307000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-319000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1115000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
110930000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
147004000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155551000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172355000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266481000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
319359000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266372000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319253000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
109000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
106000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
266481000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
319359000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5295000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6327000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
571000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
430000
CY2021Q2 us-gaap Investment Related Liabilities
InvestmentRelatedLiabilities
0
CY2020Q2 us-gaap Investment Related Liabilities
InvestmentRelatedLiabilities
10400000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47117000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-30759000
us-gaap Net Income Loss
NetIncomeLoss
-95034000
us-gaap Net Income Loss
NetIncomeLoss
-26685000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65166000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60346000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64604000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59977000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65166000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60346000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64604000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59977000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10537000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.72
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.47
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12773000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8950000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12866000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.72
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1476000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
481000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
350000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
613000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-114000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
901000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1012000
CY2021Q2 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5100000
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4700000
axon Investments In Number Of Affiliates
InvestmentsInNumberOfAffiliates
3
CY2021Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
704117000
CY2021Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
195000
CY2021Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
60000
CY2021Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
704252000
CY2021Q2 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
266379000
us-gaap Reclassifications
Reclassifications
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218795000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141259000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413814000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288421000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218795000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141259000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413814000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288421000
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
118252000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300724000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
111375000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
186909000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
113815000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300724000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163959000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275181000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
186909000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
113815000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300724000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163959000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
111222000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
275181000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2040000000.00
CY2021Q2 axon Short Term Investment
ShortTermInvestment
389050000
CY2021Q2 axon Long Term Investment
LongTermInvestment
48688000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266372000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
388895000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
48669000
CY2021Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
200000
CY2020Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
200000
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
652816000
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
401000
CY2020Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
128000
CY2020Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
653089000
CY2020Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
155443000
CY2020Q4 axon Short Term Investment
ShortTermInvestment
406667000
CY2020Q4 axon Long Term Investment
LongTermInvestment
90706000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155440000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
406525000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
90681000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3376000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
126000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
54000
axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
69000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3517000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1973000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2105000
CY2021Q2 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1186000
CY2020Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
794000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
358000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
477000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
62000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26885000
CY2021Q2 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3517000
CY2020Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3376000
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
35935000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
39194000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
55804000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
50764000
CY2021Q2 us-gaap Inventory Net
InventoryNet
91739000
CY2020Q4 us-gaap Inventory Net
InventoryNet
89958000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
11711000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
20500000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
40855000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
30156000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
42910000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
58520000
axon Equity Securities Without Readily Determinable Fair Value Gain On Sale Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueGainOnSaleOfSecurities
12300000
CY2021Q2 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5055000
CY2020Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4654000
CY2021Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
36489000
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
32455000
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
60000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
22308000
CY2021Q2 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
15755000
CY2020Q4 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
8727000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100970000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
84244000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68206000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
39487000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
36892000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1201000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3055000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
901000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3780000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3848000
CY2021Q2 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
10979000
CY2020Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
4597000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10560000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10682000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66908000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59843000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
51900000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7600000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3300000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.064
us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.191
CY2018Q2 axon Market Capitalization Goal For Tranche First Tranche
MarketCapitalizationGoalForTrancheFirstTranche
2500000000
CY2018Q2 axon Market Capitalization Goal For Tranche Incremental Increase
MarketCapitalizationGoalForTrancheIncrementalIncrease
1000000000.0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55941000
CY2021Q2 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Nine
AdjustedEBITDAGoalGoalNumberNine
125000000
CY2021Q2 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Ten
AdjustedEBITDAGoalGoalNumberTen
155000000
CY2021Q2 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Eleven
AdjustedEBITDAGoalGoalNumberEleven
175000000
CY2021Q2 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Twelve
AdjustedEBITDAGoalGoalNumberTwelve
190000000
CY2021Q2 axon Revenue Goal Goal Number Five
RevenueGoalGoalNumberFive
1410058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Thirteen
AdjustedEBITDAGoalGoalNumberThirteen
200000000
CY2021Q2 axon Revenue Goal Goal Number Six
RevenueGoalGoalNumberSix
1610058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Fourteen
AdjustedEBITDAGoalGoalNumberFourteen
210000000
CY2021Q2 axon Revenue Goal Goal Number Seven
RevenueGoalGoalNumberSeven
1810058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Fifteen
AdjustedEBITDAGoalGoalNumberFifteen
220000000
CY2021Q2 axon Revenue Goal Goal Number Eight
RevenueGoalGoalNumberEight
2010058000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Sixteen
AdjustedEBITDAGoalGoalNumberSixteen
230000000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Eleven
AdjustedEBITDAGoalGoalNumberEleven
175000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Twelve
AdjustedEBITDAGoalGoalNumberTwelve
190000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Thirteen
AdjustedEBITDAGoalGoalNumberThirteen
200000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Fourteen
AdjustedEBITDAGoalGoalNumberFourteen
210000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Fifteen
AdjustedEBITDAGoalGoalNumberFifteen
220000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Sixteen
AdjustedEBITDAGoalGoalNumberSixteen
230000000.0
CY2021Q2 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860100000
CY2021Q2 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010100000
CY2021Q2 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210100000
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Nine
AdjustedEBITDAGoalGoalNumberNine
125000000.0
CY2021Q2 axon Adjusted Ebitda Goal Goal Number Ten
AdjustedEBITDAGoalGoalNumberTen
155000000.0
CY2021Q2 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710100000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
204200000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4800000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
137549000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
33835000
us-gaap Share Based Compensation
ShareBasedCompensation
227159000
us-gaap Share Based Compensation
ShareBasedCompensation
54030000
axon Employee Deferrals Vested Percentage
EmployeeDeferralsVestedPercentage
1
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1800000
CY2020Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3800000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2800000
CY2021Q2 axon Maximum Ratio Of Liabilities To Tangible Net Worth
MaximumRatioOfLiabilitiesToTangibleNetWorth
2.50
CY2021Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
4
CY2021Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
5000000.0
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
218795000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141259000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
80866000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53082000
CY2021Q2 us-gaap Gross Profit
GrossProfit
137929000
CY2020Q2 us-gaap Gross Profit
GrossProfit
88177000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53952000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29560000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
413814000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
288421000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
152532000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
111636000
us-gaap Gross Profit
GrossProfit
261282000
us-gaap Gross Profit
GrossProfit
176785000

Files In Submission

Name View Source Status
0001558370-21-010634-index-headers.html Edgar Link pending
0001558370-21-010634-index.html Edgar Link pending
0001558370-21-010634.txt Edgar Link pending
0001558370-21-010634-xbrl.zip Edgar Link pending
axon-20210630.xsd Edgar Link pending
axon-20210630x10q.htm Edgar Link pending
axon-20210630x10q_htm.xml Edgar Link completed
axon-20210630xex31d1.htm Edgar Link pending
axon-20210630xex31d2.htm Edgar Link pending
axon-20210630xex32.htm Edgar Link pending
axon-20210630xex3d1.htm Edgar Link pending
axon-20210630_cal.xml Edgar Link unprocessable
axon-20210630_def.xml Edgar Link unprocessable
axon-20210630_lab.xml Edgar Link unprocessable
axon-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending